Business
ANP initiates ATL1102 Phase II clinical trial in DMD
ANP initiates ATL1102 Phase II clinical trial in DMD
About this update from Percheron Therapeutics Limited
[{"type":"text","content":"Percheron Therapeutics Limited has released a press release. View Attachment","length":253,"tagName":"div"}]